IKT smart money

Inhibikase Therapeutics, INC. (IKT): 1 insider buy, 5 top funds holding it in the public filings.

Insider buys, 12 months$3.0M

Insider buys

FiledWhoRoleAmountPrice
2025-11-24Sands Frank M.TenPercentOwner$3.0M$1.45

Top 100 funds holding it

#FundChangeWeightValue
3Fairmount Funds Management LLC1.11%$18M
50Siren, L.L.C.0.28%$12M
72Sphera Funds Management LTD.ADD +6%0.21%$1M
84Soleus Capital Management, L.P.ADD +3%0.82%$23M
86Adar1 Capital Management, LLCTRIM -23%0.54%$12M
Open the live smart money map